This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

MedInt And Nuance Offers Integrated Workflow Solution To Be Showcased At The Nuance Partner Pavilion At RSNA 2012

KING OF PRUSSIA, Pa., Nov. 19, 2012 /PRNewswire/ -- medInt Holdings, LLC, a Healthcare IT company offering enterprise-wide imaging solutions, and Nuance Communications, Inc. today announced the integration of their respective technologies to provide radiation dose information to radiologists.

The collaboration between these organizations comes at a critical juncture in healthcare. Radiology departments are changing rapidly, with much of their business extending outside of the traditional hospital setting. This makes oversight and compliance difficult to track and maintain. On top of that, hospitals and radiologists face a daunting regulatory environment with some states demanding full transparency when it comes to radiation dosing. In California—with other states surely to follow—SB 1237, effective July 1, 2012, requires organizations to provide radiation exposure estimates in all CT radiology reports.

To help address these regulations, medInt, through its solution Imalogix , auto-populates radiation dose information into Nuance's PowerScribe 360 | Reporting platform. "We are thrilled to work with Nuance," said John Heil, CEO of medInt. "Our solution synergies will empower radiologists with comprehensive dosing information. Imalogix is a very simple, yet elegant product that integrates automatically with PowerScribe 360 | Reporting to provide dosing information that helps simplify the workflow and reduces the chance of an error due to manual entry."

Additionally, Imalogix delivers a complete solution to hospitals and imaging centers by giving them a new view of all of their imaging information so they can improve patient safety and enterprise efficiency, while protecting margins. Imalogix is so precise it can pinpoint micro and macro-level trends, including individual scanner performance, staff utilization, protocol adherence, performance across the entire enterprise and how well an organization stacks up against regional and national benchmarks. Customized alerts point out areas that need investigation, while a dashboard allows organizations to take action.

Imalogix will be showcasing its integrated solution with PowerScribe 360 | Reporting at RSNA 2012 in the Nuance Partner Pavilion: Booth 6217 Monday, November 26th 2:30 – 4:00 PM.

Imalogix will also be featured at its Booth 1207 in the Lakeside Center. Please contact us to schedule a visit to learn more at 1-855-687-9100 ext. 103.

About medInt Holdings, LLCHeadquartered in King of Prussia, Pa., medInt Holdings, LLC is a Healthcare IT company that integrates with the diagnostic and therapeutic disciplines, turning data into usable knowledge to improve patient safety, increase quality and save lives. Its flagship product, Imalogix™, helps you manage your risk by providing the industry's only enterprise platform to protect your imaging business, your patients, your providers and your margins. For more information, please visit www.imalogix.com.

SOURCE medInt Holdings, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs